B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signaling by MAPK mutants

REACTOME PATHWAY
Reactome: R-HSA-96528171 genes22 compounds

The Signaling by MAPK mutants pathway (Reactome ID: R-HSA-9652817) involves 1 genes and is affected by 22 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

MAPK1

Compounds Affecting Signaling by MAPK mutants

#CompoundTargets HitStudies
1plumbagin [Supplementary Concept]300
2pd980597
3tyrphostin ag 14784
4alsterpaullone12
5kenpaullone8
6Clotrimazole296
7sp600125117
8fisetin78
9Progesterone299
102-Chloroadenosine 2-Chloroadenosine.300
11Benzalkonium Compounds299
12Calcimycin216
13daph2
14Diphenhydramine14
15ha10044
16isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
17Lithocholic Acid300
18Loratadine296
19Sorafenib300
20trametinib296
21trequinsin hydrochloride1
22withaferin300

About the Signaling by MAPK mutants Pathway

The Signaling by MAPK mutants pathway is catalogued in Reactome (ID: R-HSA-9652817) and involves 1 genes. In the BiohacksAI corpus, 22 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include MAPK1.